Literature DB >> 4592555

High frequency of dysphoric reactions to tetrahydrocannabinol among depressed patients.

S L Ablon, F K Goodwin.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1974        PMID： 4592555

Source DB:  PubMed          Journal:  Am J Psychiatry        ISSN： 0002-953X            Impact factor:   18.112


× No keyword cloud information.
  5 in total

1.  Cannabis and Depression.

Authors:  Daniel Feingold; Aviv Weinstein
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  Role of endocannabinoid signaling in anxiety and depression.

Authors:  Sachin Patel; Cecilia J Hillard
Journal:  Curr Top Behav Neurosci       Date:  2009

3.  Rapid increase in the prevalence of cannabis use among people with depression in the United States, 2005-17: the role of differentially changing risk perceptions.

Authors:  Lauren R Pacek; Andrea H Weinberger; Jiaqi Zhu; Renee D Goodwin
Journal:  Addiction       Date:  2019-12-20       Impact factor: 6.526

Review 4.  Endocannabinoid signaling in the etiology and treatment of major depressive illness.

Authors:  Cecilia J Hillard; Qing-song Liu
Journal:  Curr Pharm Des       Date:  2014       Impact factor: 3.116

5.  Evidence for Use of Cannabinoids in Mood Disorders, Anxiety Disorders, and PTSD: A Systematic Review.

Authors:  Corneliu N Stanciu; Mary F Brunette; Nikhil Teja; Alan J Budney
Journal:  Psychiatr Serv       Date:  2021-02-03       Impact factor: 3.084
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.